Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.21
Delayed Data
As of Dec 11
 +0.47 / +1.32%
Today’s Change
30.90
Today|||52-Week Range
36.78
+11.48%
Year-to-Date
Teva Stock Rises After Announcing Launch of Generic Viagra Competitor
Dec 11 / TheStreet.com - Paid Partner Content
Pfizer Reports Updated Data from Phase III Study on Ibrance
Dec 07 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Talazoparib Emerges Superior in EMBRACA Study
Dec 11 / Zacks.com - Paid Partner Content
Can Drug/Biotech M&A Rebound Next Year After Bleak 2017?
Dec 06 / Zacks.com - Paid Partner Content
Blueprint Medicines and Bluebird Bio Soar on ASH Announcements -- Biotech Movers
Dec 11 / TheStreet.com - Paid Partner Content
US Market Indexes Lower on Tuesday
Dec 05 / GuruFocus News - Paid Partner Content
4 Drug/Biotech Stocks That Could Be Buyout Targets in 2018
Dec 11 / Zacks.com - Paid Partner Content
Pzena Investments Buys Mylan, Hewlett Packard, Wells Fargo
Dec 05 / GuruFocus News - Paid Partner Content
Why Thousands Will Attend ASH Hematology Conference in Atlanta This Weekend
Dec 08 / TheStreet.com - Paid Partner Content
5 Top-Ranked Drug Stocks that are Broker Favorites
Dec 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close35.74
Today’s open35.79
Day’s range35.69 - 36.26
Volume14,362,928
Average volume (3 months)16,134,698
Market cap$213.0B
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+8.12%
Earnings growth (next 5 years)+6.01%
Revenue growth (last year)+8.13%
P/E ratio22.4
Price/Sales3.79
Price/Book3.64

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.16-0.19%
MRKMerck+0.77+1.39%
SNYSanofi+0.46+1.06%
ABBVAbbVie+0.52+0.54%
Data as of 4:02pm ET, 12/11/2017

Financials

Next reporting dateJanuary 30, 2018
EPS forecast (this quarter)$0.56
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts